基于全切片数字成像的肾活检间质纤维化评分可预测蛋白尿性肾小球疾病的结局
在NEPTUNE研究315例活检证实的MCD、FSGS、MN和IgAN患者中,用全切片数字图像量化间质纤维化(IF)、肾小管萎缩和间质炎症。校正临床病理诊断等变量后,IF每增加10%,eGFR下降40%或ESRD复合终点风险比为1.29(P<0.03),但与蛋白尿完全缓解无显著关联。
要点
- IF与肾小管萎缩和间质炎症高度相关(P<0.001)。
- IF中位数因诊断而异:FSGS 17、IgAN 21、MN 7、MCD 1(P<0.001)。
- 校正后IF每增加10%,ESRD/eGFR下降40%复合终点HR为1.29(P<0.03)。
核心结论
- IF程度与不同类型蛋白尿性肾小球疾病的eGFR下降风险相关,并与炎症和纤维化基因表达相关,可能在评估进展风险方面有预测价值。
研究设计与样本
- NEPTUNE研究纳入315例活检证实的患者,包括MCD 98例、FSGS 121例、MN 59例、IgAN 37例。
- 由五位病理学家在数字全切片活检图像上量化皮质IF、TA和II(%),读者间一致性高(组内相关系数>0.8)。
- 在部分患者中测量肾小管间质信使RNA表达。
- 采用多变量Cox比例风险模型评估IF与eGFR下降40%和ESRD复合终点、以及蛋白尿完全缓解的关联。
主要发现
- IF与TA(P<0.001)和II(P<0.001)高度相关。
- IF中位数因诊断而异:FSGS 17、IgAN 21、MN 7、MCD 1(P<0.001)。
- IF与基线eGFR(P<0.001)和蛋白尿(P=0.002)强相关。
- 校正临床病理诊断、年龄、种族、全球肾小球硬化、基线蛋白尿、eGFR和药物后,IF每增加10%与ESRD/40% eGFR下降的风险比为1.29(P<0.03),但与完全缓解无显著关联。
- 共有981个基因与IF显著相关(|r|>0.4,错误发现率(FDR)<0.01),包括肿瘤坏死因子、干扰素γ(IFN-γ)和转化生长因子β1(TGF-β1)等上游调控因子,以及抗原呈递和肝纤维化信号通路。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Interstitial fibrosis (IF), tubular atrophy (TA) and interstitial inflammation (II) are known determinants of progression of renal disease. Standardized quantification of these features could add value to current classification of glomerulopathies. METHODS: We studied 315 participants in the Nephrotic Syndrome Study Network (NEPTUNE) study, including biopsy-proven minimal change disease (MCD = 98), focal segmental glomerulosclerosis (FSGS = 121), membranous nephropathy (MN = 59) and IgA nephropathy (IgAN = 37). Cortical IF, TA and II were quantified (%) on digitized whole-slide biopsy images, by five pathologists with high inter-reader agreement (intra-class correlation coefficient >0.8). Tubulointerstitial messenger RNA expression was measured in a subset of patients. Multivariable Cox proportional hazards models were fit to assess association of IF with the composite of 40% decline in estimated glomerular filtration rate (eGFR) and end-stage renal disease (ESRD) and separately as well, and with complete remission (CR) of proteinuria. RESULTS: IF was highly correlated with TA (P < 0.001) and II (P < 0.001). Median IF varied by diagnosis: FSGS 17, IgAN 21, MN 7, MCD 1 (P < 0.001). IF was strongly correlated with baseline eGFR (P < 0.001) and proteinuria (P = 0.002). After adjusting for clinical pathologic diagnosis, age, race, global glomerulosclerosis, baseline proteinuria, eGFR and medications, each 10% increase in IF was associated with a hazard ratio of 1.29 (P < 0.03) for ESRD/40% eGFR decline, but was not significantly associated with CR. A total of 981 genes were significantly correlated with IF (|r| > 0.4, false discovery rate (FDR) < 0.01), including upstream regulators such as tumor necrosis factor, interferon gamma (IFN-gamma), and transforming growth factor beta 1 (TGF-B1), and signaling pathways for antigen presentation and hepatic fibrosis. CONCLUSIONS: The degree of IF is associated with risk of eGFR decline across different types of proteinuric glomerulopathy, correlates with inflammatory and fibrotic gene expression, and may have predictive value in assessing risk of progression.
引用
- Mariani LH, Martini S, Barisoni L, et al. Interstitial fibrosis scored on whole-slide digital imaging of kidney biopsies is a predictor of outcome in proteinuric glomerulopathies. Nephrol Dial Transplant. 2018. PMID: 28339906. doi:10.1093/ndt/gfw443
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。